Category: Public Health

At Colorado’s Rural Edges, Vaccines Help Assisted Living Homes Crack Open the Doors

Amid the disorganization and confusion of the vaccine distribution, smaller communities may have an advantage. In some long-term care facilities where vaccination is underway, things are looking up.

Huge Gaps in Vaccine Data Make It Next to Impossible to Know Who Got the Shots

Details about race, ethnicity and occupation are often missing as data collected nationally is scattered across scores of digital systems that don’t connect. And the CDC doesn’t require vaccinators to report occupations of recipients, even though the order in which people get shots largely depends on their job.

New Covid Cases Plunge 25% or More As Behavior Changes

End of holiday gatherings or fear of the virus may be at play – or hope for the vaccine

Can the US Keep Covid Variants in Check? Here’s What It Takes

The U.S. has fumbled almost every step of its public health response in its battle against covid-19. Experts say that must change if we’re going to outflank the variants emerging as the virus continues to mutate.

Millions allocated to vaccine research fund misused for years, US special counsel says

Read the full post on Becker's Hospital Review – Healthcare News

More US adults willing to get COVID-19 vaccine, survey finds

Read the full post on Becker's Hospital Review – Healthcare News

Confirmed UK variant cases, by state

Read the full post on Becker's Hospital Review – Healthcare News

COVID-19 hospitalizations fall, but deaths rise; US boosts states’ vaccine supplies — 6 updates

Read the full post on Becker's Hospital Review – Healthcare News

If I Have Cancer, Dementia or MS, Should I Get the Covid Vaccine?

Older patients with cancer, dementia or other serious illnesses should check with their doctors, but medical experts recommend the vaccine for most people.

Remdesivir, Given to Half of Hospitalized Covid Patients in U.S., Is Big Win for Gilead — Boosted by Taxpayers

With U.S. cases skyrocketing, demand for Gilead’s dark horse antiviral is only growing. Biden appointees propose potential legal tactics to tamp down the price for patients.